Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms

Part of paid clinical trials in Boca Raton, Florida.

Sponsor
Baptist Health South Florida
Study ID
NCT01524211
Status
Recruiting

Conditions

  • Aortic Arch Aneurysm
  • Thoracoabdominal Aortic Aneurysm

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Zenith® t-Branch — DEVICE
    The t-Branch Endovascular Graft (Zenith® t-Branch) is a tubular graft with four branches and a covered stent at the proximal end that contains barbs for additional fixation of the device. The purpose of the branches is to allow uninterrupted blood flow to visceral vessels of the aorta. The graft is designed to be connected with celiac, superior mesenteric and two renal arteries via self-expanding covered bridging stents. Although the standard Zenith t-Branch has four branches, it is anticipated that a small number of custom-made three branch devices will be included in this study for those patients in whom one of the visceral vessels is chronically thrombosed.
  • Terumo Arch Branch — DEVICE
    The Arch Branch endograft is a custom-made endograft based on the Relay thoracic stent graft platform. The device is intended to land proximally in the ascending aorta just distal to the sinotubular junction, and distally either in the native thoracic aorta for focal arch pathologies, or more extensive pathologies either extended with another commercially available thoracic endograft or mated to a pre-existing thoracic endograft, which would serve as a distal landing zone. It is constructed of polyester graft material (same as those used for the Terumo Relay Plus or Pro) sewn to self-expanding nitinol stents with suture. The graft is fully stented to provide stability and the expansile force necessary to open the lumen of the graft during deployment. Additionally, the stents provide the necessary attachment and seal of the graft to the aortic wall.

Study Details

Zenith t-Branch Study Cohort: The purpose of this study is to collect information on the Cook Zenith t-Branch endovascular stent-graft system and the Terumo Arch Branch for the treatment of aortic aneurysms. Terumo Arch Branch Study Cohort: The purpose of this additional study arm to the current IDE clinical trial is to collect a priori information on the Terumo Arch Branch Endograft for the treatment of proximal thoracic aortic pathologies that cannot be treated with conventional thoracic endografts.

Key Dates

Start date
Jan 25, 2012
Status verified
Jun 2025
Primary completion
Dec 31, 2031
Completion
Jan 31, 2032

Study Design

Enrollment
235 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Single Treatment Arm-Zenith t-Branch Cohort
    Zenith t-Branch Cohort:Those subjects eligible for enrollment will receive endovascular treatment with the investigational Zenith t-Branch Endovascular Graft.
  • Experimental: Single Treatment Arm-Terumo Arch Branch Cohort
    Terumo Arch Branch Cohort:Those subjects eligible for enrollment will receive endovascular treatment with the investigational Terumo Arch Branch Endovascular Graft.

Primary Outcome Measure

Early Mortality & Stroke [ Time Frame: 30 days post implant of the branch endografts ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Baptist Health South Florida|Boca Raton Regional Hospital (BRRH)Boca RatonFlorida33486
Lisamarie Kernicky, RN;BSN;CCRC
561-955-5239

Find similar trials in Boca Raton, FL

Related Studies